MHRA-101186-PIP01-23

Key Facts

Active Substance
Active Substance:
  • FARICIMAB
Invented Name
  • Vabysmo
  • Vabysmo
PIP Number MHRA-101186-PIP01-23
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Solution for injection
Therapeutic area
Therapeutic area:
  • Ophthamology
Conditions / Indications
Conditions / Indications:
  • Treatment of choroidal neovascularisation secondary to pathologic myopia
Route(s) of administration
Route(s) of administration:
  • Intravitreal use
PIP applicant
Decision Type
Decision Type
W: decision granting a waiver in all age groups for the listed condition(s).
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):FARICIMAB.pdf
Published Date 03/10/2024